Cytokinetics' (CYTK) omecamtiv Approval Highly Likely, Data Are Encouraging and Suggest Useful Benefit, Reiterate Buy - H. C. Wainwright

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. SPY
3. GLOB
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to Cytokinetics' (CYTK) omecamtiv Approval Highly Likely, Data Are Encouraging and Suggest Useful Benefit, Reiterate Buy - H. C. Wainwright
CYTOKINETICS (NASDAQ: CYTK) Delayed: 74.13 +0.68 (0.93%)
Previous Close $73.45    52 Week High $13.18 
Open $72.70    52 Week Low $6.00 
Day High $74.26    P/E N/A 
Day Low $72.12    EPS $-1.24 
Volume 1,756,949